LEXINGTON, Ky., Aug. 19, 2024 /PRNewswire/ -- A new study by researchers from Weill Cornell Medicine and the epigenetic company, TruDiagnostic,…
Media Release COPENHAGEN, Denmark; August 16, 2024 Rayne Waller joins as Executive Vice President and Chief Technology OfficerBrad Bailey appointed…
- Q2 Revenues Increased 40%- Q2 Operating Expenses Decreased 17.7%- Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content-…
Results demonstrate Esopredict's ability to predict the likelihood of progression to high-grade dysplasia or esophageal adenocarcinoma in patients with Barrett's…
SALT LAKE CITY, Aug. 15, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a…
NEW YORK, Aug. 14, 2024 /PRNewswire/ -- The global chromatography market size is estimated to grow by USD 3.99 billion…
Revealia™, the world’s most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024…
Declared development candidate MGX-001 for the treatment of hemophilia A; plans to present 12-month NHP durability study data in September…
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:…
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun…